跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-DEXLANSOPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
APO-DEXLANSOPRAZOLE
Authorized
STANDARD
APO-DEXLANSOPRAZOLE
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4be41e30f5aaf72d
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
4be41e30f5aaf72d
Drug Approval Canada Name
APO-DEXLANSOPRAZOLE
Product Name
APO-DEXLANSOPRAZOLE
Status
Marketed
Status Date
2024-02-26
Original Market Date
2024-02-26
Din
02528991
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Nasogastric , Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC06 DEXLANSOPRAZOLE
Atc Name
a 02 bc 06
Aig Number
0152766001
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
DEXLANSOPRAZOLE
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4be41e30f5aaf72d
Type
Standard
Back to Health Canada Approvals